CONVINCE
2023
Comparison of High-Dose Haemodiafiltration with High-Flux Haemodialysis
In 1,360 prevalent haemodialysis patients, high-dose haemodiafiltration reduced all-cause mortality compared with conventional high-flux haemodialysis.
Result
Efficacy: All-cause mortalityHR 0.77 (95% CI 0.65-0.93)
Below 1 favours high-dose haemodiafiltration, above 1 favours conventional high-flux haemodialysis.
- Absolute difference
- 4.6 points
- NNT
- 22
Absolute difference and NNT are derived from the event rates.
- Subtopic
- Haemodiafiltration
- Design
- International open-label RCT, median 30-month follow-up
- Relevance
- Important: one of several pillars.
- Source
- Blankestijn PJ, et al. N Engl J Med. 2023;389(8):700-709.doi 10.1056/NEJMoa2304820
Discussion & critique
First clearly positive haemodiafiltration mortality trial; a relatively healthy European cohort limits generalisability.